查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439931

藥品合約包裝 - 全球市場考量、競爭狀況、市場預測 (2030)

Pharmaceutical Contract Packaging - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2022年全球藥品合約包裝市場規模將達179.6422億美元，2030年將達289.3235億美元，2024-2030年預測期內複合年增長率為8.32%。由於日益嚴格的品質和滅菌要求以及智慧包裝解決方案的日益採用，該市場呈現出顯著的市場成長。此外，缺乏內部包裝能力和專業知識、預算限制、製藥公司數量不斷增加、全球新藥和仿製藥上市數量不斷增加以及市場上主要參與者的存在等因素正在推動對藥品合約包裝的需求服務市場，創造需求。因此，預計在 2024 年至 2030 年的預測期內，市場將以顯著的複合年增長率成長。

藥品合約包裝市場動態

藥品合約包裝市場的關鍵驅動因素之一是全球對藥品的需求不斷增長。

例如，印度化學品和化肥部提供的2020-2022年年度報告指出，2020-2022年藥品年度總收入為28999.8億印度盧比。由於全球經濟成長、人口老化、患者數量增加以及新產品的推出，全球製藥業在世界許多地區呈現巨大的成長。因此，藥品需求的增加將增加對藥品合約包裝的需求，因為企業需要原料和成品（包括藥品和設備）的包裝服務。此外，許多藥品供應商已經意識到，將商業和臨床包裝外包給藥品合約製造商可以增加他們的利潤，預計這將在預測期內擴大合約包裝市場。

此外，市場上新藥和仿製藥的增加將增加對許多初級和二級包裝（例如瓶子和泡罩）的需求。根據 FDA Center for Drug Evaluation and Research（CDER）的數據，截至 2022 年 10 月，已有 29 種新藥獲得批准。此外，根據同一數據，2022年將有50個新藥獲批，2020年將有53個新藥獲批。此外，2020年仿製藥計畫核准或臨時核准的仿製藥申請有948個。因此，FDA批准的新藥數量的增加推動了全球藥品合約包裝市場，因為需要以瓶子、小瓶、泡罩包裝等形式包裝的新藥的推出將增加對包裝服務的需求。產生積極影響

此外，主要參與者採取的策略措施同樣將推動未來幾年對藥品合約包裝的需求。例如，2020年6月，PCI Pharma宣佈與合約製造組織和藥品供應服務公司Experic達成合作協議，探索臨床和商業製造、包裝和供應鏈服務，推動共同成長。

此外，2022 年 11 月，Carton Service Inc. 的子公司 Pharma Packaging Solutions 被 Tjoapack 收購。Tjoapack 對 PPS 的收購可能會創造一個機會，以發展成為藥品合約包裝和分銷網路服務領域的新的全球領導者。

因此，上述因素將共同推動2022-2028年預測期間的整體藥品合約包裝市場。

然而，包裝成本的增加、監控問題和缺乏標準化可能會阻礙預測期內（2022-2028年）藥品合約包裝市場的成長。

前所未有的 COVID-19 大流行對藥品合約包裝市場產生了重大影響。這是因為在疫情爆發初期，由於政府嚴格的封鎖規定，一些行業關閉了生產設施和其他業務。此外，全球封鎖和對進出口貿易活動的嚴格限制導致了病毒的遏制，擾亂了全球供應鏈並擾亂了藥品和醫療器材的製造。相反，隨著治療COVID-19的小瓶和藥品等需求的增加，藥品合約包裝市場呈現快速增長，這導致行業製造商集中資源並加快生產速度，並促進了包裝的發展。過程。此外，針對COVID-19的免疫疫苗的需求急劇增加，這增加了對藥品合約包裝服務的需求。因此，上述因素正在推動藥品合約包裝市場，預計預測期將保持不變。

本報告提供了全球藥品合約包裝市場的研究和分析，包括市場規模和預測、驅動因素和挑戰、公司和產品概況。

目錄

第一章藥品合約包裝市場報告簡介

第二章藥品合約包裝市場概要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

第四章藥品合約包裝市場主要因素分析

  • 藥品合約包裝市場的驅動因素
  • 藥品合約包裝市場的限制與挑戰
  • 藥品合約包裝市場機遇

第五章藥品合約包裝市場波特五力分析

第六章 COVID-19對藥品合約包裝市場的影響分析

第七章 藥品合約包裝市場佈局

  • 按服務類型
    • 初級包裝
    • 二次包裝
    • 三級包裝
  • 按材質
    • 塑膠/聚合物
    • 紙/紙板
    • 玻璃
    • 鋁箔
    • 其他
  • 區域
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第八章 藥品合約包裝市場的公司與產品概況

  • ROPACK INC.
  • Sharp Services, LLC
  • Reed-Lane
  • Unicep
  • PCI Pharma Services
  • Jones Healthcare Group.
  • Almac Group
  • AmeriPac.
  • MJS Packaging
  • Carton Service Inc.
  • Nelipak BV
  • Aphena Pharma Solutions.
  • Tjaopak
  • Central Pharma
  • Wasdell Packaging Group
  • Daklapack Group
  • Experic
  • Amcor plc
  • Tripak Pharmaceuticals
  • CCL Industries Inc.

第9章 KOL觀點

第10章項目方法

第 11 章關於 DelveInsight

第十二章 免責聲明與聯絡我們

Product Code: DIMDCL0612

Pharmaceutical Contract Packaging Market By Service Type (Primary Packaging [Bottles, Vials, Ampoules, Blister Packs, And Others], Secondary Packaging, And Tertiary Packaging), By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing stringent quality requirements specially to the sterilization and lack of in-house packaging capabilities, expertise, and budget constraints

The global pharmaceutical contract packaging market was valued at USD 17,964.22 million in 2022 and is likely to register a CAGR of 8.32% during the forecast period from 2024 to 2030 to reach USD 28,932.35 million by 2030. The pharmaceutical contract packaging market is observing remarkable market growth owing to the factors such as increasingly stringent quality and sterilization requirements and the growing adoption of smart packaging solutions. Further, the lack of in-house packaging capabilities, expertise, and budget constraints, the rising number of pharmaceutical players, the rising launch of new and generic drugs across the globe, the presence of key players in the market, and other factors will create a requisite for the pharmaceutical contract packaging service in the market. Therefore, the market for pharmaceutical contract packaging is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Pharmaceutical Contract Packaging Market Dynamics:

One of the key aspects driving the pharmaceutical contract packaging market is the rising demand for pharmaceutical products globally.

For instance, the annual report for 2020-2022 provided by the Ministry of Chemicals & Fertilizers, India, stated that the total annual turnover of Pharmaceuticals was INR 2,89,998 crore for the year 2020-2022. The global pharmaceutical industry in different regions around the globe is growing exponentially, driven by global economic growth, a growing aging population, a surging patient pool, and new product launches. Thus, the increasing demand for pharmaceutical products will in turn increase the demand for pharmaceutical contract packaging as the companies will be requiring packaging services for their raw materials or end-products (including drugs or devices). Moreover, many pharmaceutical vendors recognized that the profits could be increased by outsourcing the commercial and clinical packaging to a pharmaceutical contractor, thereby expected to expand the contract packaging market during the forecast period.

Further, the increasing number of novel and generic drugs in the market will increase the demand for many primary or secondary packing such as bottles, and blisters, among others. As per the FDA's Center for Drug Evaluation and Research (CDER), till October 2022, nearly 29 novel drugs were approved. Further, as per the same source, 50 novel drugs were approved in 2022 and 53 novel drugs in 2020. Also, the generic drug program approved or tentatively approved 948 generic drug applications during the year 2020. Thus, the increase in the number of new drugs approved by the FDA will positively impact the global pharmaceutical contract packaging market as the launch of new drugs will increase the demand for packing services that require packaging in the form of bottles, vials, blister packs, and others.

Moreover, strategic steps taken by the key players will in turn propel the demand for pharmaceutical contract packing in the upcoming years. For instance, in June 2020, PCI Pharma announced that the company has entered into a partnership agreement with Experic, a contract manufacturing organization, and pharmaceutical supply service company, to explore clinical and commercial manufacturing, packaging, and supply chain services driving collective growth for both parties.

Also, in November 2022, Pharma Packaging Solutions, a part of Carton Service Inc., was acquired by Tjoapack. Tjoapack's acquisitions of PPS are likely to lead toward creating opportunities to develop a new worldwide leader in pharmaceutical contractual packaging and distribution network services.

Therefore, the factors stated above collectively will drive the overall pharmaceutical contract packaging market during the forecast period from 2022 - 2028.

However, increased costs of packaging, monitoring issues, and lack of standardization, may hamper the growth of the pharmaceutical contract packaging market during the forecast period (2022 - 2028).

The unprecedented COVID-19 pandemic has had a substantial effect on the pharmaceutical contract packaging market. This is because, in the initial days of the pandemic, several industries had stopped their production units and other operations owing to the imposition of strict lockdown rules by the government. Also, the lockdown across the globe and the stringent regulations on import-export trade activities that had led to the containment of the virus, disrupted the global supply chain, thereby disturbing the manufacturing of the drugs and devices. Contrarily, as the demand for vials, medicines, and other drugs increases to treat the coronavirus infection, the market for pharmaceutical contract packing witnessed a sudden rise, owing to which, the manufacturers in the industry scrambled for their resources and pushed for faster manufacturing and packaging processes. Moreover, the demand for vaccines increased exponentially to immunize people against COVID-19, thereby increasing the demand for pharmaceutical contract packaging services. Henceforth, the afore-said factors were responsible for driving the market of pharmaceutical contract packaging and are anticipated to do the same during the forecast period.

Pharmaceutical Contract Packaging Market Segment Analysis:

Pharmaceutical Contract Packaging Market by Service Type (Primary Packaging [Bottles, Vials, Ampoules, Blister Packs, and Others], Secondary Packaging, and Tertiary Packaging), Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the service type segment of the pharmaceutical contract packaging market, the bottles segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the growing requirement for pharmaceutical bottles worldwide and the increasing adoption of pharmaceutical bottles for unit dose packaging.

Also, plastic bottle filling will significantly grow due to its various advantages, including light-weightiness that further saves space and transportation, and freight charges. Plastic bottles are not prone to breakage and help with necessary cost-savings associated with glass bottles.

Additionally, the solid dosages, liquid dosages, and liquid suspensions are filled in glass, metal, and plastic bottles.

Moreover, the increasing demand for injectable pharmaceuticals is significantly driving the growth of glass bottles in the pharmaceutical sector as glass bottles are used to store injectable drugs. Also, the injectable drugs which need to be stored under freezing temperatures are usually stored in glass bottles.

Further, the increasing expansion and funding activities by the key players in bottle packing services will positively influence the growth of the bottle segment in the market. For instance, in January 2022, Aphena Pharma Solutions, an organization providing pharmaceutical contract packaging services, announced that the company had added ten high-speed bottling lines leveraging its USD 21 million investment in solid dosage contract packaging. The company further intends to install 30 more high-speed lines in its newly acquired 500,000 sq. ft. facility to increase the monthly capacity to over 80 million bottles to target the pharmaceutical solid dose packaging industry.

Therefore, owing to the above-mentioned factors, the demand for the bottles rises, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global pharmaceutical contract packaging market during the forecast period.

North America is expected to dominate the overall Pharmaceutical Contract Packaging Market:

Among all the regions, North America is expected to hold the largest share in global pharmaceutical contract packaging in 2022 and is expected to do the same during the forecast period from 2024-2030. This can be ascribed to the increasing demand for pharmaceutical contract packaging among the region increasing launches of generic or novel drugs, increasing government initiatives concerned with sterilized packaging, technological advancement, the presence of domicile of key players and others will be contributing to the growth of the pharmaceutical contract packaging market in North America.

Further, increasing the adoption of different packaging methods to meet the expectations of changing consumer preferences and rising environmental concerns have stimulated the demand for sustainable contract packaging in the pharmaceutical industry.

Additionally, the rising penetration of automation in pharmaceutical contract packaging has minimized human handling errors and will increase the market growth in the region.

Further, many contract packaging companies have been investing in expanding their presence in the sector through acquisitions and partnerships. For instance, in September 2020, Essentra Packaging announced the purchase of a 3C! Based in North Carolina, Packaging is a designer and manufacturer of cartons, literature, labels, and packaging primarily for the pharmaceutical industry. Such acquisitions allow companies like Essentra Packaging to enhance their position in the pharmaceutical packaging space and provide opportunities to grow in the pharmaceutical manufacturing hub in various regions including North America.

Moreover, the presence of the major market players such as Amcor PLC, Winpak ltd., Sonoco products co., and others will create a positive outlook for the market in North America.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North America region in the pharmaceutical contract packaging market.

Pharmaceutical Contract Packaging Market Key Players:

Some of the key market players operating in the pharmaceutical contract packaging market include ROPACK INC., Sharp Services, LLC, Reed-Lane, Unicep, PCI Pharma Services, Jones Healthcare Group., Almac Group, AmeriPac., MJS Packaging, Carton Service Inc., Nelipak BV, Aphena Pharma Solutions., Tjaopak, Central Pharma, Wasdell Packaging Group, Daklapack Group, Experic, Amcor plc, Tripak Pharmaceuticals, CCL Industries Inc., and others.

Recent Developmental Activities in the Pharmaceutical Contract Packaging Market:

In April 2022, Catalent completed a USD 14 million expansion for increasing biologics packaging capabilities and capacity at its Bloomington, Indiana facility.

In May 2022, Sharp, a contract packaging, clinical supply services company owned by UDG Healthcare plc, purchased new land as part of a USD 17 million investment in its Conshohocken, PA location. This land purchase will enable Sharp to add future capacity for cGMP packaging services and is part of a broader USD 43 million investment into its Pennsylvania operations, increasing the firm's blister packaging capacity by over 35%.

In September 2020, Legacy Pharmaceutical Packaging expanded its services, including 3PL services, covering supply chain transparency solutions and retail pharma product procurement for over-the-counter medications. In addition to this, the company also expanded its open-space facility near its St Louis, MO, headquarters from 215,000 ft2 to 500,000 ft2.

Key Takeaways from the Pharmaceutical Contract Packaging Market Report Study

  • Market size analysis for current pharmaceutical contract packaging market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the pharmaceutical contract packaging market.
  • Top key products/services/developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global pharmaceutical contract packaging market.
  • Various opportunities available for the other competitor in the pharmaceutical contract packaging market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current pharmaceutical contract packaging market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for pharmaceutical contract packaging market growth in the coming future?

Target Audience who can be benefited from this Pharmaceutical Contract Packaging Market Report Study

  • Pharmaceutical contract packaging providers
  • Research organizations and consulting companies
  • Pharmaceutical contract packaging -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in pharmaceutical contract packaging
  • Various end users who want to know more about the pharmaceutical contract packaging market and the latest developments in the pharmaceutical contract packaging market.

Frequently Asked Questions for the Pharmaceutical Contract Packaging Market:

1. What is pharmaceutical contract packaging?

Pharmaceutical contract packaging is a type of service in which the company provides all the packaging functions from the simplest to the most complex and from the glamorous to the hazardous.

2. What is the global market for pharmaceutical contract packaging?

The global pharmaceutical contract packaging market was valued at USD 17,964.22 million in 2022 and is likely to register a CAGR of 8.32% during the forecast period from 2024 to 2030 to reach USD 28,932.35 million by 2030.

3. What are the drivers for the global pharmaceutical contract packaging market?

The pharmaceutical contract packaging market is witnessing positive market growth owing to the factors such as the increasingly stringent quality requirements, the rising number of pharmaceutical players across the globe, and the rising efforts towards sterilization of the end products. Further, the lack of in-house packaging capabilities, expertise, and budget constraints among small-scale companies will create an exigency for the pharmaceutical contract packaging market.

4. Who are the key players operating in the global pharmaceutical contract packaging market?

Some of the key market players operating in the pharmaceutical contract packaging market include ROPACK INC., Sharp Services, LLC, Reed-Lane, Unicep, PCI Pharma Services, Jones Healthcare Group., Almac Group, AmeriPac., MJS Packaging, Carton Service Inc., Nelipak BV, Aphena Pharma Solutions., Tjaopak, Central Pharma, Wasdell Packaging Group, Daklapack Group, Experic, Amcor plc, Tripak Pharmaceuticals, CCL Industries Inc., and others.

5. Which region has the highest share of the pharmaceutical contract packaging market?

Among all the regions, North America is estimated to hold the major revenue share in the global pharmaceutical contract packaging market. This can be ascribed to the increasing launches of generic or novel drugs, increasing government initiatives concerned with sterilized packaging, technological advancement, and the presence of key players in the region are the reasons which act as a supportive factor for the North America pharmaceutical contract packaging market growth.

Table of Contents

1.Pharmaceutical Contract Packaging Market Report Introduction

2. Pharmaceutical Contract Packaging Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

4. Pharmaceutical Contract Packaging Market Key Factors Analysis

  • 4.1. Pharmaceutical Contract Packaging Market Drivers
    • 4.1.1. Increasing stringent quality requirements
    • 4.1.2. Lack of in-house packaging capabilities, expertise, and budget constraints
    • 4.1.3. The rising number of pharmaceutical industries across the globe
    • 4.1.4. Growing adoption of smart packaging solutions
  • 4.2. Pharmaceutical Contract Packaging Market Restraints and Challenges
    • 4.2.1. Increased costs of packaging
    • 4.2.2. Monitoring issues and lack of standardization
  • 4.3. Pharmaceutical Contract Packaging Market Opportunities
    • 4.3.1. Rising outsourcing of pharmaceutical packaging to contract packagers in emerging countries
    • 4.3.2. Rising capacity expansions & investments in expanding bottling and filling services

5. Pharmaceutical Contract Packaging Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Pharmaceutical Contract Packaging Market

7. Pharmaceutical Contract Packaging Market Layout

  • 7.1. By Service Type
    • 7.1.1. Primary Packaging
      • 7.1.1.1. Bottles
      • 7.1.1.2. Vials
      • 7.1.1.3. Ampoules
      • 7.1.1.4. Blister Packs
      • 7.1.1.5. Others
    • 7.1.2. Secondary Packaging
    • 7.1.3. Tertiary Packaging
  • 7.2. By Material
    • 7.2.1. Plastics & Polymers
    • 7.2.2. Paper & Paperboard
    • 7.2.3. Glass
    • 7.2.4. Aluminum Foil
    • 7.2.5. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.1.2. Canada Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.1.3. Mexico Pharmaceutical Contract Packaging Market in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.2. Germany Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.4. Italy Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.5. Spain Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Pharmaceutical Contract Packaging Market in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.2. Japan Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.3. India Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.4. Australia Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.5. South Korea Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia Pacific Pharmaceutical Contract Packaging Market in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.4.2. Africa Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.4.3. South America Pharmaceutical Contract Packaging Market in USD million (2021-2030)

8. Pharmaceutical Contract Packaging Market Company and Product Profiles

  • 8.1. ROPACK INC.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Sharp Services, LLC
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Reed-Lane
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Unicep
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. PCI Pharma Services
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Jones Healthcare Group.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Almac Group
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. AmeriPac.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. MJS Packaging
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Carton Service Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Nelipak BV
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Aphena Pharma Solutions.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Tjaopak
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Central Pharma
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Wasdell Packaging Group
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Daklapack Group
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Experic,
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Amcor plc
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Tripak Pharmaceuticals
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. CCL Industries Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Pharmaceutical Contract Packaging Market
  • Table 3: Pharmaceutical Contract Packaging Market Analysis in Global (2021-2030)
  • Table 4: Pharmaceutical Contract Packaging Market Analysis in Global by Service Type (2021-2030)
  • Table 5: Pharmaceutical Contract Packaging Market Analysis in Global by Material (2021-2030)
  • Table 6: Pharmaceutical Contract Packaging Market Analysis in Global by Geography (2021-2030)
  • Table 7: Pharmaceutical Contract Packaging Market Analysis in North America (2021-2030)
  • Table 8: Pharmaceutical Contract Packaging Market Analysis in North America by Country (2021-2030)
  • Table 9: Pharmaceutical Contract Packaging Market Analysis in the US (2021-2030)
  • Table 10: Pharmaceutical Contract Packaging Market Analysis in Canada (2021-2030)
  • Table 11: Pharmaceutical Contract Packaging Market Analysis in Mexico (2021-2030)
  • Table 12: Pharmaceutical Contract Packaging Market Analysis in Europe (2021-2030)
  • Table 13: Pharmaceutical Contract Packaging Market Analysis in Europe by Country (2021-2030)
  • Table 14: Pharmaceutical Contract Packaging Market Analysis in France (2021-2030)
  • Table 15: Pharmaceutical Contract Packaging Market Analysis in Germany (2021-2030)
  • Table 16: Pharmaceutical Contract Packaging Market Analysis in the UK (2021-2030)
  • Table 17: Pharmaceutical Contract Packaging Market Analysis in Italy (2021-2030)
  • Table 18: Pharmaceutical Contract Packaging Market Analysis in Spain (2021-2030)
  • Table 19: Pharmaceutical Contract Packaging Market Analysis in the Rest of Europe (2021-2030)
  • Table 20: Pharmaceutical Contract Packaging Market Analysis in Asia-Pacific (2021-2030)
  • Table 21: Pharmaceutical Contract Packaging Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 22: Pharmaceutical Contract Packaging Market Analysis in China (2021-2030)
  • Table 23: Pharmaceutical Contract Packaging Market Analysis in Japan (2021-2030)
  • Table 24: Pharmaceutical Contract Packaging Market Analysis in India (2021-2030)
  • Table 25: Pharmaceutical Contract Packaging Market Analysis in Australia (2021-2030)
  • Table 26: Pharmaceutical Contract Packaging Market Analysis in South Korea (2021-2030)
  • Table 27: Pharmaceutical Contract Packaging Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Table 28: Pharmaceutical Contract Packaging Market Analysis in the Rest of the World (2021-2030)
  • Table 29: Pharmaceutical Contract Packaging Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 30: Pharmaceutical Contract Packaging Market Analysis in the Middle East (2021-2030)
  • Table 31: Pharmaceutical Contract Packaging Market Analysis in Africa (2021-2030)
  • Table 32: Pharmaceutical Contract Packaging Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Pharmaceutical Contract Packaging Market
  • Figure 3: Pharmaceutical Contract Packaging Market Analysis in Global (2021-2030)
  • Figure 4: Pharmaceutical Contract Packaging Market Analysis in Global by Service Type (2021-2030)
  • Figure 5: Pharmaceutical Contract Packaging Market Analysis in Global by Material (2021-2030)
  • Figure 6: Pharmaceutical Contract Packaging Market Analysis in Global by Geography (2021-2030)
  • Figure 7: Pharmaceutical Contract Packaging Market Analysis in North America (2021-2030)
  • Figure 8: Pharmaceutical Contract Packaging Market Analysis in North America by Country (2021-2030)
  • Figure 9: Pharmaceutical Contract Packaging Market Analysis in the US (2021-2030)
  • Figure 10: Pharmaceutical Contract Packaging Market Analysis in Canada (2021-2030)
  • Figure 11: Pharmaceutical Contract Packaging Market Analysis in Mexico (2021-2030)
  • Figure 12: Pharmaceutical Contract Packaging Market Analysis in Europe (2021-2030)
  • Figure 13: Pharmaceutical Contract Packaging Market Analysis in Europe by Country (2021-2030)
  • Figure 14: Pharmaceutical Contract Packaging Market Analysis in France (2021-2030)
  • Figure 15: Pharmaceutical Contract Packaging Market Analysis in Germany (2021-2030)
  • Figure 16: Pharmaceutical Contract Packaging Market Analysis in the UK (2021-2030)
  • Figure 17: Pharmaceutical Contract Packaging Market Analysis in Italy (2021-2030)
  • Figure 18: Pharmaceutical Contract Packaging Market Analysis in Spain (2021-2030)
  • Figure 19: Pharmaceutical Contract Packaging Market Analysis in the Rest of Europe (2021-2030)
  • Figure 20: Pharmaceutical Contract Packaging Market Analysis in Asia-Pacific (2021-2030)
  • Figure 21: Pharmaceutical Contract Packaging Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 22: Pharmaceutical Contract Packaging Market Analysis in China (2021-2030)
  • Figure 23: Pharmaceutical Contract Packaging Market Analysis in Japan (2021-2030)
  • Figure 24: Pharmaceutical Contract Packaging Market Analysis in India (2021-2030)
  • Figure 25: Pharmaceutical Contract Packaging Market Analysis in Australia (2021-2030)
  • Figure 26: Pharmaceutical Contract Packaging Market Analysis in South Korea (2021-2030)
  • Figure 27: Pharmaceutical Contract Packaging Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Figure 28: Pharmaceutical Contract Packaging Market Analysis in the Rest of the World (2021-2030)
  • Figure 29: Pharmaceutical Contract Packaging Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 30: Pharmaceutical Contract Packaging Market Analysis in the Middle East (2021-2030)
  • Figure 31: Pharmaceutical Contract Packaging Market Analysis in Africa (2021-2030)
  • Figure 32: Pharmaceutical Contract Packaging Market Analysis in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Market Opportunities
  • Figure 36: PORTER's Five Force Analysis